Table 1.
Clinicopathologic characteristics of the BC patients and cancer-free controls
| Category | M0 |
M1 |
CFC |
|||
|---|---|---|---|---|---|---|
| Media | SD | Media | SD | Media | SD | |
| Age | 55.98 | 12.32 | 57.77 | 11.21 | 57 | 11.25 |
| n | % | n | % | n | % | |
| Tumor stage | ||||||
| 0 | 46 | 36.51 | ||||
| I–II | 17 | 13.49 | ||||
| I–III | 27 | 21.43 | ||||
| IV | 36 | 28.57 | ||||
| Subtype | ||||||
| Luminal | 33 | 75 | 28 | 77.77 | ||
| Her2 | 2 | 4.54 | 1 | 2.77 | ||
| Triple negative | 9 | 20.45 | 7 | 19.4 | ||
| Metastasis location | ||||||
| Bone | 25 | 69.44 | ||||
| Visceral | 25 | 69.44 | ||||
| Bone & visceral | 16 | 44.44 | ||||
| Number of metastatic sites | ||||||
| 1 | 8 | 22.22 | ||||
| 2 | 10 | 27.77 | ||||
| ≥3 | 18 | 50.00 | ||||